Genmab | GEN - Caixa e Equivalentes

Preço das Ações
1,690.00
Mudança Diária
35.00 2.11%
Mensal
-1.34%
Anual
20.80%
Q2 Previsão
1,628.53




Caixa e Equivalentes Alterar Data
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 131.06M 3.6M 2026-03
Amgen USD 9.13B 316M 2025-12
argenx SE USD 4.3B 2.21B 2025-09
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 5.9B 1.34B 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Demant DKK 1.33B 188M 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
Galapagos EUR 87.87M 23.41M 2025-12
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 767M 363M 2025-09
GRIFOLS EUR 801M 242.31M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
Insmed USD 510.44M 175.68M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.25B 1.08B 2025-09
Novartis USD 11.44B 1.88B 2025-12
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12